Chemed Corporation (NYSE: CHE) reported Q4 EPS of $2.32, $0.05 better than the analyst estimate of $2.27. Revenue for the quarter came in at $428 million versus the consensus estimate of $423.83 million.

GUIDANCE:

Chemed Corporation sees FY2018 EPS of $10.60-$10.85, versus the consensus of $10.01.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.